| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Denali Therapeutics Inc. (DNLI) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 58 sells. DNLI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 26.00M | $625.21M | - | |
| CEO | 296.8K | $7.14M | - | |
| Other | 282.8K | $6.80M | - | |
| Other | 216.6K | $5.21M | - | |
| Dir | 38.2K | $918.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2021 | Krognes Steve E.74 | CFO And Treasurer | Sale+OE | 1,448 | $74.68 | $108,134.54 | -5.2% | |
| Feb 9, 2021 | Schuth Alexander O.75 | COO And Secretary | Sale+OE | 1,468 | $74.80 | $109,809.30 | -0.1% | |
| Feb 9, 2021 | Ho Carole73 | Chief Medical Officer | Sale+OE | 1,470 | $74.68 | $109,784.53 | -0.3% | |
| Feb 4, 2021 | Schuth Alexander O.75 | COO And Secretary | Sell | 10,000 | $67.84 | $678,360.75 | -0.6% | |
| Feb 1, 2021 | Watts Ryan J.77 | President And CEO | Sell | 18,334 | $68.44 | $1,254,818.65 | -0.3% | |
| Jan 15, 2021 | Krognes Steve E.74 | CFO And Treasurer | Sell | 50,000 | $71.45 | $3,572,556.34 | -1.3% | |
| Jan 4, 2021 | Schuth Alexander O.75 | COO And Secretary | Sell | 70,000 | $74.95 | $5,246,408.46 | -0.7% | |
| Jan 4, 2021 | Watts Ryan J.77 | President And CEO | Sell | 88,334 | $74.96 | $6,621,781.67 | -0.2% | |
| Dec 21, 2020 | Schenkein David P59 | Director | Sell | 30,000 | $90.05 | $2,701,582.00 | -53.4% | |
| Dec 14, 2020 | Bratton Douglas K | 10% Owner | Sell | 64,624 | $80.14 | $5,179,284.87 | -5.2% |